Skip to main navigation Skip to search Skip to main content

Differences in post-authorization adverse events of biopharmaceuticals and small molecules: patients or products?

Activity: Talk or presentation › Invited talk › Academic

Period17 Apr 2012
Event titlePoster presentation at the 5th TI Pharma Spring Meeting
Event typeOther
LocationUtrecht, The NetherlandsShow on map